Signant Health Launches Partner Program

Signant Health, a provider of technology for clinical research,has announced the launch of the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions. 

Chris Crucitti, Chief Commercial Officer of Signant Health explains, “This programputs in place the infrastructure needed to ensure the success of our CRO partners across Signant’s solution portfolio. We will remain ever committed to the traditional support of our partners via protocol design and optimization, eCOA data collection, data quality oversight, patient engagement, eConsent and clinical supply management. However, the needs and challenges of CROs are more complex and expansive today than ever before, just as they are for the sponsors we jointly support. The time is right for us to make a landmark investment in our partners so that together we can more powerfully impact data quality and clinical trial execution. When our partners succeed, clinical research succeeds.”

With approximately 50 percent of clinical research activities being outsourced by pharmaceutical companies to CROs that offer full services across the entire drug development process, there is both a growing need for CROs to deliver technology in support of services and an increasing demand to leverage technology to differentiate those services. This Partner Program is designed to extend Signant’s 20 years of experience-in clinical and scientific practices, operations, and global requirements-to its partners.